131 related articles for article (PubMed ID: 12489808)
1. Increased activity of the renal kallikrein-kinin system in autosomal dominant polycystic kidney disease in rats, but not in humans.
Braun C; Kleemann T; Birck R; Hilgenfeldt U; Riester U; Tschöpe C; van der Woude FJ; Rohmeiss P
Int Immunopharmacol; 2002 Dec; 2(13-14):1949-56. PubMed ID: 12489808
[TBL] [Abstract][Full Text] [Related]
2. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
[TBL] [Abstract][Full Text] [Related]
3. Autoregulation of renal blood flow and pressure-dependent renin release in autosomal dominant polycystic kidney disease of rats.
Braun C; Lüdicke C; Rebsch W; Gretz N; van der Woude FJ; Rohmeiss P
Nephrol Dial Transplant; 1996; 11 Suppl 6():52-7. PubMed ID: 9044329
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease.
Zheng D; Wolfe M; Cowley BD; Wallace DP; Yamaguchi T; Grantham JJ
J Am Soc Nephrol; 2003 Oct; 14(10):2588-95. PubMed ID: 14514736
[TBL] [Abstract][Full Text] [Related]
5. Low-salt diet downregulates plasma but not tissue kallikrein-kinin system.
Hilgenfeldt U; Puschner T; Riester U; Finsterle J; Hilgenfeldt J; Ritz E
Am J Physiol; 1998 Jul; 275(1):F88-93. PubMed ID: 9689009
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin excretion is increased in severely hyperglycemic streptozotocin-diabetic rats.
Tschöpe C; Gavriluk V; Reinecke A; Seidl U; Riester U; Hilgenfeldt U; Ritz E; Unger T
Immunopharmacology; 1996 Jun; 33(1-3):344-8. PubMed ID: 8856182
[TBL] [Abstract][Full Text] [Related]
7. [Unilateral renal denervation and the renal kallikrein-bradykinin system in the rat].
Bohlender J; Nussberger J; Amstutz C; Birkhäuser F; Thalmann GN; Imboden H
Ann Cardiol Angeiol (Paris); 2013 Jun; 62(3):144-8. PubMed ID: 23746686
[TBL] [Abstract][Full Text] [Related]
8. Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
Zittema D; Boertien WE; van Beek AP; Dullaart RP; Franssen CF; de Jong PE; Meijer E; Gansevoort RT
Clin J Am Soc Nephrol; 2012 Jun; 7(6):906-13. PubMed ID: 22516290
[TBL] [Abstract][Full Text] [Related]
9. Plasma Kallikrein-Kinin system mediates immune-mediated renal injury in trichloroethylene-sensitized mice.
Wang H; Zhang JX; Ye LP; Li SL; Wang F; Zha WS; Shen T; Wu C; Zhu QX
J Immunotoxicol; 2016 Jul; 13(4):567-79. PubMed ID: 27027470
[TBL] [Abstract][Full Text] [Related]
10. Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function.
Azurmendi PJ; Fraga AR; Galan FM; Kotliar C; Arrizurieta EE; Valdez MG; Forcada PJ; Stefan JS; Martin RS
Nephrol Dial Transplant; 2009 Aug; 24(8):2458-63. PubMed ID: 19332866
[TBL] [Abstract][Full Text] [Related]
11. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
[TBL] [Abstract][Full Text] [Related]
12. [The effect of hypervolemia on electrolyte level and and level of volume regulating hormones in patients with autosomal dominant polycystic kidney disease].
Michalski A; Grzeszczak W
Pol Arch Med Wewn; 1996 Oct; 96(4):329-43. PubMed ID: 9082344
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of sirtuin 1 (SIRT1) levels in autosomal dominant polycystic kidney disease.
Ozkan Kurtgoz P; Karakose S; Cetinkaya CD; Erkus E; Guney I
Int Urol Nephrol; 2022 Jan; 54(1):131-135. PubMed ID: 33864594
[TBL] [Abstract][Full Text] [Related]
14. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
[TBL] [Abstract][Full Text] [Related]
15. Rat tissue kallikrein releases a kallidin-like peptide from rat low-molecular-weight kininogen.
Hilgenfeldt U; Stannek C; Lukasova M; Schnölzer M; Lewicka S
Br J Pharmacol; 2005 Dec; 146(7):958-63. PubMed ID: 16231010
[TBL] [Abstract][Full Text] [Related]
16. Roles of renal dopamine and kallikrein-kinin systems in antihypertensive mechanisms of exercise in rats.
Maeda H; Sasaguri M; Sakai T; Kinoshita A; Koga M; Noda K; Tsuji E; Ideishi M; Arakawa K
Hypertens Res; 2000 Sep; 23(5):511-9. PubMed ID: 11016807
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin-induced natriuresis mediated by the renal kallikrein-kinin system in anesthetized male rats.
Adachi K; Majima M; Katori M; Nishijima M
Jpn J Pharmacol; 1995 Mar; 67(3):243-52. PubMed ID: 7630042
[TBL] [Abstract][Full Text] [Related]
18. Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation.
Ho TA; Godefroid N; Gruzon D; Haymann JP; Maréchal C; Wang X; Serra A; Pirson Y; Devuyst O
Kidney Int; 2012 Nov; 82(10):1121-9. PubMed ID: 22718190
[TBL] [Abstract][Full Text] [Related]
19. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
Raina R; Lou L; Berger B; Vogt B; Do AS; Cunningham R; Vasavada P; Herrmann K; Dell K; Simonson M
BMC Nephrol; 2016 Feb; 17():22. PubMed ID: 26923419
[TBL] [Abstract][Full Text] [Related]
20. Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats.
Tschöpe C; Reinecke A; Seidl U; Yu M; Gavriluk V; Riester U; Gohlke P; Graf K; Bader M; Hilgenfeldt U; Pesquero JB; Ritz E; Unger T
Am J Physiol; 1999 Dec; 277(6):H2333-40. PubMed ID: 10600853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]